Chronic inflammatory demyelinating polyneuropathy;Chronisch inflammatorische demyelinisierende polyneuropathie

Nervenarzt

Volumn 74, Issue 4, 2003, Pages 320-333

  Koller H ^a,b   Kieseier, B C ^a   Jander, S ^a   Hartung, H P ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Diagnostic criteria; Electrophysiology; Pathogenesis; Therapy

Indexed keywords

CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; DEMYELINATION; DIFFERENTIAL DIAGNOSIS; ELECTROPHYSIOLOGY; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MOTOR DYSFUNCTION; NERVE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NEUROPATHY; REVIEW; SENSORY DYSFUNCTION;

AUTOANTIGENS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; ELECTRODIAGNOSIS; HUMANS; MACROPHAGES; MAGNETIC RESONANCE IMAGING; NERVE FIBERS, MYELINATED; NEUROLOGIC EXAMINATION; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; PROGNOSIS; SURAL NERVE; T-LYMPHOCYTES;

EID: 0038183905     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-003-1486-5     Document Type: Review

References (112)

1. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force (1991) Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 41:617-618
2. Adam AM, Atkinson PF, Hall SM, Hughes RA, Taylor WA (1989) Chronic experimental allergic neuritis in Lewis rats. Neuropathol Appl Neurobiol 15:249-264
3. Andersson PB, Yuen E, Parko K, So YT (2000) Electrodiagnostic features of hereditary neuropathy with liability to pressure palsies. Neurology 54:40-44
4. Austin JH (1958) Recurrent polyneuropahties and their corticosteroid treatment. Brain 81:157-194
5. Barnett MH, Pollard JD, Davies L, McLeod JG (1998) Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 21:454-460
6. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR (1989) Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 46:878-884
7. Bosboom WM, van den Berg LH, Franssen H, Giesbergen PC, Flach HZ, van Putten AM, Veldman H, Wokke JH (2001) Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy. Brain 124:2427-2438
8. Bosboom WM, Van den Berg LH, Mollee I, Sasker LD, Jansen J, Wokke JH, Logtenberg T (2001) Sural nerve T-cell receptor Vbeta gene utilization in chronic inflammatory demyelinating polyneuropathy and vasculitic neuropathy. Neurology 56:74-81
9. Bouchard C, Lacroix C, Plante V, Adams D, Chedru F, Guglielmi JM, Said G (1999) Clinico-pathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 52:498-503
10. Brannagan TH, 3rd, Pradhan A, Heiman Patterson T et al. (2002) High-dose cyclophosphamide without stem-cell rescue for refractory CIDP. Neurology 58:1856-1858
11. Chaudhry V, Cornblath DR, Griffin JW, O'Brien R, Drachman DB (2001) Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases. Neurology 56:94-96
12. Chiang MC, Lin YH, Pan CL, Tseng TJ, Lin WM, Hsieh ST (2002) Cutaneous innervation in chronic inflammatory demyelinating polyneuropathy. Neurology 59:1094-1098
13. Cocito D, Ciaramitaro P, Isoardo G et al. (2002) Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP. J Neurol 249:719-722
14. Cocito D, Isoardo G, Ciaramitaro P et al. (2001) Terminal latency index in polyneuropathy with IgM paraproteinemia and anti-MAG antibody. Muscle Nerve 24:1278-1282
15. Comi G, Roveri L, Swan A et al. (2002) A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy. J Neurol 249:1370-1377
16. Connolly AM (2001) Chronic inflammatory demyelinating polyneuropathy in childhood. Pediatr Neurol 24:177-182
17. Dyck PJ (2000) Atypical varieties of chronic inflammatory demyelinating neuropathies. Lancet 355:1293-1294
18. Dyck PJ, Lais AC, Ohta M, Bastron JA, Okazaki H, Groover RV (1975) Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 50:621-637
19. Dyck PJ, O'Brien P, Swanson C, Low P, Daube J (1985) Combined azathioprine and prednisone in chronic inflammatory-demyelinating polyneuropathy. Neurology 35:1173-1176
20. Eurelings M, Notermans NC, Franssen H, Van Es HW, Ramos LM, Wokke JH, van den Berg LH (2001) MRI of the brachial plexus in polyneuropathy associated with monoclonal gammopathy. Muscle Nerve 24:1312-1318
21. Federico P, Zochodne DW, Hahn AF, Brown WF, Feasby TE (2000) Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study. Neurology 55:1256-1262
22. Gabriel CM, Howard R, Kinsella N et al. (2000) Prospective study of the usefulness of sural nerve biopsy. J Neurol Neurosurg Psychiatry 69:442-446
23. Gorson KC, Allam G, Ropper AH (1997) Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology 48:321-328
24. Gorson KC, Ropper AH, Adelman LS, Weinberg DH (2000) Influence of diabetes mellitus on chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 23:37-43
25. Gorson KC, Ropper AH, Clark BD, Dew RB, 3rd, Simovic D, Allam G (1998) Treatment of chronic inflammatory demyelinating polyneuropathy with interferon-alpha 2a. Neurology 50:84-87
26. Goto H, Matsuo H, Nakane S, Izumoto H Fukudome T, Kambara C, Shibuya N (2001) Plasmapheresis affects T-helper type-1/T-helper type2 balance of circulating peripheral lymphocytes. Ther Apher 5:494-496
27. Grant GA, Britz GW, Goodkin R, Jarvik JG, Maravilla K, Kliot M (2002) The utility of magnetic resonance imaging in evaluating peripheral nerve disorders. Muscle Nerve 25:314-331
28. Hadden RD, Bensa S, Lunn MP, Hughes RA (2002) Immunoadsorption inferior to plasma exchange in a patient with chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 72:644-646
29. Hadden RD, Sharrack B, Bensa S, Soudain SE, Hughes RA (1999) Randomized trial of interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 53:57-61
30. Hahn AF, Bolton CF, Pillay N, Chalk C, Benstead T, Bril V, Shumak K, Vandervoort MK, Feasby TE (1996) Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study. Brain 119 (Pt 4):1055-1066
31. Hahn AF, Bolton CF, Zochodne D, Feasby TE (1996) Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study. Brain 119 (Pt4):1067-1077
32. Haq RU, Fries TJ, Pendlebury WW, Kenny MJ, Badger GJ, Tandan R (2000) Chronic inflammatory demyelinating polyradiculoneuropathy: a study of proposed electrodiagnostic and histologic criteria. Arch Neurol 57:1745-1750
33. Hartung HP, Reiners K, Schmidt B, Stoll G, Toyka KV (1991) Serum interleukin-2 concentrations in Guillain-Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis. Ann Neurol 30:48-53
34. Harvey GK, Pollard JD, Schindhelm K, Antony J (1987) Chronic experimental allergic neuritis. An electrophysiological and histological study in the rabbit. J Neurol Sci 81:215-225
35. Hattori N, Misu K, Koike H, Ichimura M, Nagamatsu M, Hirayama M, Sobue G (2001) Age of onset influences clinical features of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 184:57-63
36. Hughes R, Bensa S, Willison H et al. (2001) Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50:195-201
37. Hughes RA (2002) Systematic reviews of treatment for inflammatory demyelinating neuropathy. J Anat 200:331-339
38. Illes Z, Kondo T, Newcombe J, Oka N, Tabira T, Yamamura T (2000) Differential expression of NK T-cell V alpha 24 J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J Immunol 164:4375-4381
39. Inaba A, Yokota T, Otagiri A, Nishimura T, Saito Y, Ichikawa T, Mizusawa H (2002) Electrophysiological evaluation of conduction in the most proximal motor root segment. Muscle Nerve 25:608-611
40. Inaba A, Yokota T, Saito Y, Ichikawa T, Mizusawa H (2001) Proximal motor conduction evaluated by transcranial magnetic stimulation in acquired inflammatory demyelinating neuropathies. Clin Neurophysiol 112:1936-1945
41. Katz JS, Barohn RJ, Kojan S, Wolfe GI, Nations SP, Saperstein DS, Amato AA (2002) Axonal multifocal motor neuropathy without conduction block or other features of demyelination. Neurology 58:615-620
42. Katz JS, Saperstein DS, Gronseth G, Amato AA, Barohn RJ (2000) Distal acquired demyelinating symmetric neuropathy. Neurology 54:615-620
43. Katz JS, Wolfe GI, Bryan WW, Jackson CE, Amato AA, Barohn RJ (1997) Electrophysiologic findings in multifocal motor neuropathy. Neurology 48:700-707
44. Kawasaki T, Oka N, Akiguchi I, Miyamoto K, Kaji R, Shibasaki H (2001) Up-regulation of cyclooxygenase-2 in inflammatory demyelinating neuropathy. Acta Neuropathol (Berl) 101:154-158
45. Kiefer R, Dangond F, Mueller M, Toyka KV, Hafler DA, Hartung HP (2000) Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies. J Neurol Neurosurg Psychiatry 69:362-368
46. Kiefer R, Kieseier BC, Bruck W, Hartung HP, Toyka KV (1998) Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies. Brain 121 (Pt3):469-479
47. Kiefer R, Kieseier BC, Stoll G, Hartung HP (2001) The role of macrophages in immune-mediated damage to the peripheral nervous system. Prog Neurobiol 64:109-127
48. Kieseier BC, Clements JM, Pischel HB, Wells GM, Miller K, Gearing AJ, Hartung HP (1998) Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barre syndrome. Ann Neurol 43:427-434
49. Kieseier BC, Dalakas MC, Hartung HP (2002) Immune mechanisms in chronic inflammatory demyelinating neuropathy. Neurology 59:7-12
50. Kieseier BC, Tani M, Mahad D et al. (2002) Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10. Brain 125:823-834
51. Kuwabara S, Ogawara K, Misawa S, Mori M, Hattori T (2002) Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 72:37-42
52. Leppert D, Hughes P, Huber S et al. (1999) Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy. Neurology 53:62-70
53. Lozeron P, Nahum L, Lacroix C, Ropert A, Guglielmi JM, Said G (2002) Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients. J Neurol 249:569-575
54. Lunn MP, Manji H, Choudhary PP, Hughes RA, Thomas PK (1999) Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry 66:677-680
55. Mariette X, Brouet JC, Chevret S et al. (2000) A randomised double blind trial versus placebo does not confirm the benefit of alpha-interferon in polyneuropathy associated with monoclonal IgM. J Neurol Neurosurg Psychiatry 69:279-280
56. Marzo ME, Tintore M, Fabregues O, Montalban X, Codina A (1998) Chronic inflammatory demyelinating polyneuropathy during treatment with interferon-alpha. J Neurol Neurosurg Psychiatry 65:604
57. Mathey EK, Pollard JD, Armati PJ (1999) TNF alpha, IFN gamma and IL-2 mRNA expression in CIDP sural nerve biopsies. J Neurol Sci 163:47-52
58. McCombe PA, Pollard JD, McLeod JG (1987) Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. Brain 110 (Pt6):1617-1630
59. McLeod JG, Pollard JD, Macaskill P, Mohamed A, Spring P, Khurana V (1999) Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol 46:910-913
60. Mehndiratta MM, Hughes RA (2002) Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev: CD002062
61. Melendez-Vasquez C, Redford J, Choudhary PP et al. (1997) Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol 73:124-134
62. Mendell JR, Barohn RJ, Freimer ML et al. (2001) Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 56:445-449
63. Meriggioli MN, Rowin J (2000) Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha. Muscle Nerve 23:433-435
64. Merkies IS, Schmitz PI, Van Der Meche FG, Samijn JP, Van Doorn PA (2002) Psychometric evaluation of a new handicap scale in immune-mediated polyneuropathies. Muscle Nerve 25:370-377
65. Merkies IS, Schmitz PI, van der Meche FG, Samijn JP, van Doorn PA (2002) Quality of life complements traditional outcome measures in immune-mediated polyneuropathies. Neurology 59:84-91
66. Merkies IS, Schmitz PI, van der Meche FG, van Doorn PA (2000) Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology 54:943-949
67. Midroni G, de Tilly LN, Gray B, Vajsar J (1999) MRI of the cauda equina in CIDP: clinical correlations. J Neurol Sci 170:36-44
68. Misawa S, Kuwabara S, Mori M, Kawaguchi N, Yoshiyama Y, Hattori T (2001) Serum levels of tumor necrosis factor-alpha in chronic inflammatory demyelinating polyneuropathy. Neurology 56:666-669
69. Molenaar DS, Vermeulen M, de Haan R (1998) Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 64:84-89
70. Molenaar DS, Vermeulen M, de Haan RJ (2002) Comparison of electrodiagnostic criteria for demyelination in patients with chronic inflammatory demyelinating polyneuropathy (CIDP). J Neurol 249:400-403
71. Mori K, Hattori N, Sugiura M, Koike H, Misu K, Ichimura M, Hirayama M, Sobue G (2002) Chronic inflammatory demyelinating polyneuropathy presenting with features of GBS. Neurology 58:979-982
72. Mowzoon N, Sussman A, Bradley WG (2001) Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis. J Neurol Sci 185:119-122
73. Murata K, Dalakas MC (2000) Expression of the co-stimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNAs in chronic inflammatory demyelinating polyneuropathy. Brain 123 (Pt 8):1660-1666
74. Mygland A, Monstad P (2003) Chronic acquired demyelinating symmetric polyneuropathy classified by pattern of weakness. Arch Neurol 60:260-264
75. Nicolas G, Maisonobe T, Le Forestier N, Leger JM, Bouche P (2002) Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 25:26-30
76. Nobile-Orazio E, Cappellari A, Meucci N et al. (2002) Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block. J Neurol Neurosurg Psychiatry 72:761-766
77. Olney RK (1999) Consensus criteria for the diagnosis of partial conduction block. Muscle Nerve 22 [Suppl 8]:225-229
78. Pfeiffer G, Wicklein EM, Wittig K (2000) Sensitivity and specificity of different conduction block criteria. Clin Neurophysiol 111:1388-1394
79. Pollard JD (2002) Chronic inflammatory demyelinating polyradiculoneuropathy. Curr Opin Neurol 15:279-283
80. Previtali SC, Archelos JJ, Hartung HP (1998) Expression of integrins in experimental autoimmune neuritis and Guillain-Barre syndrome. Ann Neurol 44:611-621
81. Previtali SC, Feltri ML, Archelos JJ, Quattrini A, Wrabetz L, Hartung H (2001) Role of integrins in the peripheral nervous system. Prog Neurobiol 64:35-49
82. Priori A, Cinnante C, Pesenti A et al. (2002) Distinctive abnormalities of motor axonal strength-duration properties in multifocal motor neuropathy and in motor neurone disease. Brain 125:2481-2490
83. Pritchard J, Mukherjee R, Hughes RA (2002) Risk of relapse of Guillain-Barre syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunisation. J Neurol Neurosurg Psychiatry 73:348-349
84. Rotta FT, Sussman AT, Bradley WG, Ram Ayyar D, Sharma KR, Shebert RT (2000) The spectrum of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 173:129-139
85. Ryan MM, Grattan-Smith PJ, Procopis PG, Morgan G, Ouvrier RA (2000) Childhood chronic inflammatory demyelinating polyneuropathy: clinical course and long-term outcome. Neuromuscul Disord 10:398-406
86. Sabatelli M, Madia F, Mignogna T, Lippi G, Quaranta L, Tonali P (2001) Pure motor chronic inflammatory demyelinating polyneuropathy. J Neurol 248:772-777
87. Said G (2002) Chronic inflammatory demyelinative polyneuropathy. J Neurol 249:245-253
88. Salomon B, Rhee L, Bour Jordan H et al. (2001) Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. J Exp Med 194:677-684
89. Saperstein DS, Katz JS, Amato AA, Barohn RJ (2001) Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 24:311-324
90. Schmid CD, Stienekemeier M, Oehen S et al. (2000) Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance. J Neurosci 20:729-735
91. Schmidt B, Toyka KV, Kiefer R, Full J, Hartung HP, Pollard J (1996) Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve 19:474-487
92. Sghirlanzoni A, Solari A, Ciano C, Mariotti C, Fallica E, Pareyson D (2000) Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients. Neurol Sci 21:31-37
93. Sharma KR, Cross J, Ayyar DR, Martinez-Arizala A, Bradley WG (2002) Diabetic demyelinating polyneuropathy responsive to intravenous immunoglobulin therapy. Arch Neurol 59:751-757
94. Sharma KR, Cross J, Farronay O, Ayyar DR, Shebert RT, Bradley WG (2002) Demyelinating neuropathy in diabetes mellitus. Arch Neurol 59:758-765
95. Simmons Z, Albers JW, Bromberg MB, Feldman EL (1993) Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy. Neurology 43:2202-2209
96. Simmons Z, Albers JW, Bromberg MB, Feldman EL (1995) Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy. Brain 118 Pt 2):359-368
97. Stojkovic T, de Seze J, Hurtevent JF, Arndt C, Beaume A, Hache JC, Vermersch P (2000) Visual evoked potentials study in chronic idiopathic inflammatory demyelinating polyneuropathy. Clin Neurophysiol 111:2285-2291
98. Taniguchi N, Itoh K, Wang Y et al. (2000) Sonographic detection of diffuse peripheral nerve hypertrophy in chronic inflammatory demyelinating polyradiculoneuropathy. J Clin Ultrasound 28:488-491
99. Toyka KV, Hartung HP (1996) Chronic inflammatory polyneuritis and neuropathies. Curr Opin Neurol 9:240-250
100. Umapathi T, Hughes R (2002) Mycophenolate in treatment-resistant inflammatory neuropathies. Eur J Neurol 9:683-685
101. Umapathi T, Hughes RA, Nobile-Orazio E, Leger JM (2002) Immunosuppressive treatment for multifocal motor neuropathy. Cochrane Database Syst Rev: CD003217
102. Uncini A, De Angelis MV, Di Muzio A et al. (1999) Chronic inflammatory demyelinating polyneuropathy in diabetics: motor conductions are important in the differential diagnosis with diabetic polyneuropathy. Clin Neurophysiol 110:705-711
103. Van den Berg-Vos RM, Van den Berg LH et al. (2000) Multifocal inflammatory demyelinating neuropathy: a distinct clinical entity? Neurology 54:26-32
104. van Dijk GW, Notermans NC, Franssen H, Wokke JH (1999) Development of weakness in patients with chronic inflammatory demyelinating polyneuropathy and only sensory symptoms at presentation: a long-term follow-up study. J Neurol 246:1134-1139
105. Van Es HW, Van den Berg LH, Franssen H et al. (1997) Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy. Neurology 48:1218-1224
106. Van Schaik IN, Winer JB, De Haan R, Vermeulen M (2002) Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev: CD001797
107. Verghese J, Bieri PL, Gellido C, Schaumburg HH, Herskovitz S (2001) Peripheral neuropathy in young-old and old-old patients. Muscle Nerve 24:1476-1481
108. Vermeulen M, Van Oers MH (2002) Successful autologous stem cell transplantation in a patient with chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 72:127-128
109. Wilson JR, Stittsworth JD, Jr., Kadir A, Fisher MA (1998) Conduction velocity versus amplitude analysis: evidence for demyelination in diabetic neuropathy. Muscle Nerve 21:1228-1230
110. Winer J, Hughes S, Cooper J, Ben-Smith A, Savage C (2002) gamma delta T-cells infiltrating sensory nerve biopsies from patients with inflammatory neuropathy. J Neurol 249:616-621
111. Yan WX, Archelos JJ, Hartung HP, Pollard JD (2001) PO protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50:286-292
112. Yan WX, Taylor J, Andrias-Kauba S, Pollard JD (2000) Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients. Ann Neurol 47:765-775